Arca Biopharma | ABIO - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 1.51B 2.41B 2025-12
Arca Biopharma USD -29.58M 694K 2025-12
Biogen USD 377.7M 433.7M 2026-03
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 7.49B 4.2B 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Grifols EUR 257.85M 190.87M 2024-12
Laboratory Of America USD 8.73B 8.54B 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Otsuka Holdings JPY 130.23B 54.96B 2026-03
Pfizer USD 5.18B 6.82B 2026-03
United Therapeutics USD 444M 6M 2025-12